Advocacy intelligence hub — real-time data for patient organizations
University of Ulm
TOBI: FDA approved
Management of cystic fibrosis patients with P.aeruginosa.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
TOBRAMYCIN
Eli Lilly
Patient Assistance Programs1
TOBI
Mylan Specialty LP
Cayston
(aztreonam)Orphan drugstandardGilead Sciences, Inc.
12.1 Mechanism of Action Aztreonam is an antibacterial drug [see Clinical Pharmacology (12.4) ] .
Browse all Pneumonia caused by Pseudomonas aeruginosa infection news →
David Paterson, Professor, md
National University of Singapore
📍 PITTSBURGH, PA
Jean-Jacques Rouby, MD, PhD
La Pitie-Salpetriere hospital
Manfred Weiss, MD, MBA
University Ulm, University Hospital Ulm
Anne Sedlag, Biochemist
University Ulm, Institute of Microbiology and Biotechnology
Violetta Georgescu
Kenta Biotech Ltd
View all Pneumonia caused by Pseudomonas aeruginosa infection specialists →